Edgewise Therapeutics Shares Rise on Takeover Speculation
Edgewise Therapeutics (EWTX) saw its stock price surge by 12% following reports that the biopharmaceutical company has attracted takeover interest. Market speculation suggests the firm has engaged financial advisers to explore potential strategic options or acquisition deals. The movement reflects broader activity in the biotechnology sector, where M&A interest remains a significant driver of volatility. While no official merger agreement has been announced, the involvement of advisers indicates that the company is actively evaluating its position in the market.
Tickers: $EWTX
Topics: Biotechnology M&A Stock Price Movement
Read the full article at Seeking Alpha
Part of the story Edgewise Therapeutics Shares Rise Following Reports of Potential Takeover Interest (2 articles)